130 related articles for article (PubMed ID: 38225255)
1. An updated PREDICT breast cancer prognostic model including the benefits and harms of radiotherapy.
Grootes I; Wishart GC; Pharoah PDP
NPJ Breast Cancer; 2024 Jan; 10(1):6. PubMed ID: 38225255
[TBL] [Abstract][Full Text] [Related]
2. An updated PREDICT breast cancer prognostication and treatment benefit prediction model with independent validation.
Candido Dos Reis FJ; Wishart GC; Dicks EM; Greenberg D; Rashbass J; Schmidt MK; van den Broek AJ; Ellis IO; Green A; Rakha E; Maishman T; Eccles DM; Pharoah PDP
Breast Cancer Res; 2017 May; 19(1):58. PubMed ID: 28532503
[TBL] [Abstract][Full Text] [Related]
3. PREDICT: a new UK prognostic model that predicts survival following surgery for invasive breast cancer.
Wishart GC; Azzato EM; Greenberg DC; Rashbass J; Kearins O; Lawrence G; Caldas C; Pharoah PD
Breast Cancer Res; 2010; 12(1):R1. PubMed ID: 20053270
[TBL] [Abstract][Full Text] [Related]
4. Incorporating progesterone receptor expression into the PREDICT breast prognostic model.
Grootes I; Keeman R; Blows FM; Milne RL; Giles GG; Swerdlow AJ; Fasching PA; Abubakar M; Andrulis IL; Anton-Culver H; Beckmann MW; Blomqvist C; Bojesen SE; Bolla MK; Bonanni B; Briceno I; Burwinkel B; Camp NJ; Castelao JE; Choi JY; Clarke CL; Couch FJ; Cox A; Cross SS; Czene K; Devilee P; Dörk T; Dunning AM; Dwek M; Easton DF; Eccles DM; Eriksson M; Ernst K; Evans DG; Figueroa JD; Fink V; Floris G; Fox S; Gabrielson M; Gago-Dominguez M; García-Sáenz JA; González-Neira A; Haeberle L; Haiman CA; Hall P; Hamann U; Harkness EF; Hartman M; Hein A; Hooning MJ; Hou MF; Howell SJ; ; ; Ito H; Jakubowska A; Janni W; John EM; Jung A; Kang D; Kristensen VN; Kwong A; Lambrechts D; Li J; Lubiński J; Manoochehri M; Margolin S; Matsuo K; Taib NAM; Mulligan AM; Nevanlinna H; Newman WG; Offit K; Osorio A; Park SK; Park-Simon TW; Patel AV; Presneau N; Pylkäs K; Rack B; Radice P; Rennert G; Romero A; Saloustros E; Sawyer EJ; Schneeweiss A; Schochter F; Schoemaker MJ; Shen CY; Shibli R; Sinn P; Tapper WJ; Tawfiq E; Teo SH; Teras LR; Torres D; Vachon CM; van Deurzen CHM; Wendt C; Williams JA; Winqvist R; Elwood M; Schmidt MK; García-Closas M; Pharoah PDP
Eur J Cancer; 2022 Sep; 173():178-193. PubMed ID: 35933885
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling for guiding adjuvant chemotherapy decisions in women with early breast cancer: an evidence-based and economic analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(23):1-57. PubMed ID: 23074401
[TBL] [Abstract][Full Text] [Related]
6. PREDICT Plus: development and validation of a prognostic model for early breast cancer that includes HER2.
Wishart GC; Bajdik CD; Dicks E; Provenzano E; Schmidt MK; Sherman M; Greenberg DC; Green AR; Gelmon KA; Kosma VM; Olson JE; Beckmann MW; Winqvist R; Cross SS; Severi G; Huntsman D; Pylkäs K; Ellis I; Nielsen TO; Giles G; Blomqvist C; Fasching PA; Couch FJ; Rakha E; Foulkes WD; Blows FM; Bégin LR; van't Veer LJ; Southey M; Nevanlinna H; Mannermaa A; Cox A; Cheang M; Baglietto L; Caldas C; Garcia-Closas M; Pharoah PD
Br J Cancer; 2012 Aug; 107(5):800-7. PubMed ID: 22850554
[TBL] [Abstract][Full Text] [Related]
7. Individual prognosis at diagnosis in nonmetastatic prostate cancer: Development and external validation of the PREDICT Prostate multivariable model.
Thurtle DR; Greenberg DC; Lee LS; Huang HH; Pharoah PD; Gnanapragasam VJ
PLoS Med; 2019 Mar; 16(3):e1002758. PubMed ID: 30860997
[TBL] [Abstract][Full Text] [Related]
8. Independent validation of the PREDICT breast cancer prognosis prediction tool in 45,789 patients using Scottish Cancer Registry data.
Gray E; Marti J; Brewster DH; Wyatt JC; Hall PS;
Br J Cancer; 2018 Oct; 119(7):808-814. PubMed ID: 30220705
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of using prognostic information to select women with breast cancer for adjuvant systemic therapy.
Williams C; Brunskill S; Altman D; Briggs A; Campbell H; Clarke M; Glanville J; Gray A; Harris A; Johnston K; Lodge M
Health Technol Assess; 2006 Sep; 10(34):iii-iv, ix-xi, 1-204. PubMed ID: 16959170
[TBL] [Abstract][Full Text] [Related]
10. Tumour profiling tests to guide adjuvant chemotherapy decisions in early breast cancer: a systematic review and economic analysis.
Harnan S; Tappenden P; Cooper K; Stevens J; Bessey A; Rafia R; Ward S; Wong R; Stein RC; Brown J
Health Technol Assess; 2019 Jun; 23(30):1-328. PubMed ID: 31264581
[TBL] [Abstract][Full Text] [Related]
11. Validation of the PREDICT Prognostication Tool in US Patients With Breast Cancer.
Stabellini N; Cao L; Towe CW; Miller ME; Sousa-Santos AH; Amin AL; Montero AJ
J Natl Compr Canc Netw; 2023 Oct; 21(10):1011-1019.e6. PubMed ID: 37856198
[TBL] [Abstract][Full Text] [Related]
12. External Validation of PATHFx Version 3.0 in Patients Treated Surgically and Nonsurgically for Symptomatic Skeletal Metastases.
Anderson AB; Wedin R; Fabbri N; Boland P; Healey J; Forsberg JA
Clin Orthop Relat Res; 2020 Apr; 478(4):808-818. PubMed ID: 32195761
[TBL] [Abstract][Full Text] [Related]
13. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
14. Prognostic models for newly-diagnosed chronic lymphocytic leukaemia in adults: a systematic review and meta-analysis.
Kreuzberger N; Damen JA; Trivella M; Estcourt LJ; Aldin A; Umlauff L; Vazquez-Montes MD; Wolff R; Moons KG; Monsef I; Foroutan F; Kreuzer KA; Skoetz N
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD012022. PubMed ID: 32735048
[TBL] [Abstract][Full Text] [Related]
15. Multidimensional Machine Learning Personalized Prognostic Model in an Early Invasive Breast Cancer Population-Based Cohort in China: Algorithm Validation Study.
Zhong X; Luo T; Deng L; Liu P; Hu K; Lu D; Zheng D; Luo C; Xie Y; Li J; He P; Pu T; Ye F; Bu H; Fu B; Zheng H
JMIR Med Inform; 2020 Nov; 8(11):e19069. PubMed ID: 33164899
[TBL] [Abstract][Full Text] [Related]
16. Bridging the Age Gap: a prognostic model that predicts survival and aids in primary treatment decisions for older women with oestrogen receptor-positive early breast cancer.
Ward SE; Holmes GR; Morgan JL; Broggio JW; Collins K; Richards PD; Reed MWR; Wyld L
Br J Surg; 2020 Nov; 107(12):1625-1632. PubMed ID: 32602959
[TBL] [Abstract][Full Text] [Related]
17. External validation and clinical utility assessment of PREDICT breast cancer prognostic model in young, systemic treatment-naïve women with node-negative breast cancer.
Wang Y; Broeks A; Giardiello D; Hauptmann M; Jóźwiak K; Koop EA; Opdam M; Siesling S; Sonke GS; Stathonikos N; Ter Hoeve ND; van der Wall E; van Deurzen CHM; van Diest PJ; Voogd AC; Vreuls W; Linn SC; Dackus GMHE; Schmidt MK
Eur J Cancer; 2023 Dec; 195():113401. PubMed ID: 37925965
[TBL] [Abstract][Full Text] [Related]
18. Estimation and external validation of a new prognostic model for predicting recurrence-free survival for early breast cancer patients in the UK.
Campbell HE; Gray AM; Harris AL; Briggs AH; Taylor MA
Br J Cancer; 2010 Sep; 103(6):776-86. PubMed ID: 20823886
[TBL] [Abstract][Full Text] [Related]
19. [Relation of breast cancer tumour stage and the degree of registration in a population-based cancer registry].
Katalinic A; Holzmann M; Kunze U
Gesundheitswesen; 2003; 65(8-9):509-15. PubMed ID: 14505270
[TBL] [Abstract][Full Text] [Related]
20. Development of a prediction model for breast cancer based on the national cancer registry in Taiwan.
Huang CC; Chan SY; Lee WC; Chiang CJ; Lu TP; Cheng SH
Breast Cancer Res; 2019 Aug; 21(1):92. PubMed ID: 31409418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
